Paul Krugman Confesses: "I Was Wrong About Inflation" Establishment-favorite economist Paul Krugman has declared the obvious: "I was wrong...
Nearly 6 percent of children who presented to the Emergency Department (ED) with COVID-19 reported symptoms of long COVID 90 days later, according to a...
Corinne Le Goff Less than 12 months into her job leading the commercial rollout of one of the world’s biggest-selling biotech products, Moderna’s Covid-19...
Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets The post Pfizer, Flynn fined £70m in resurrected...
Pritzker Honed His Presidential Stump Speech In Florida... With Hatred And Dishonesty By Mark Glennon of Wirepoints “We saw a future president,”...
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began...
BIRMINGHAM, Ala. – The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of...
Roche’s tiragolumab flop earlier this quarter set the program back at least a year, Severin Schwan revealed on the company’s Q2 call — but the outgoing...
RealSelf, the Seattle-based cosmetic treatment review platform, laid off 11 employees, or about 4.7% of its workforce this week. Chief Marketing Officer...
Long COVID patients are taking desperate measures in the hope of getting better. It’s time to increase our focus on testing potential long COVID treatments...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
Amid predictions of HIV advances unraveling during Covid, Gilead Sciences is doubling down on prevention, treatment options and on-the-ground community...
With the rise of Omicron last year, there have been a few subvariants introduced — especially BA.2 and BA.5 in the US. Now, there’s another one...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
Global markets have been erratic, as volatility continues vengeance. A major index… The post Buzz on the Bullboards: Surveying sector opportunities appeared...
AstraZeneca’s prophylactic treatment for Covid-19, known as Evusheld, has survived where other mAbs failed, showing efficacy for the immunocompromised...
While most people recover from COVID-19 within a week or two, up to one-third of survivors experience persistent or new symptoms weeks and months after...
Do you have these top high-yield dividend stocks on your watchlist right now? The post 3 High Yield Dividend Stocks To Watch Today appeared first on...
Yep, Actuator is coming to you a day early — mostly because it felt a bit weird to drop the robotics newsletter right in the middle...
A Japanese health ministry panel on Wednesday delayed emergency approval for an oral treatment against COVID-19 that has been developed by Shionogi &...
Discover good stocks to invest in right now that are positioning themselves for explosive growth over the next ten years. The post Good Stocks to Invest...
With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both deals on The post The big squeeze? appeared first on...
SAN FRANCISCO, CA—A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal (BET) proteins,...
The newly created role will be a unique driver of employee engagement.
While the road has certainly been rocky for billionaire Bob Duggan’s biotech amidst a bear market and FDA troubles, Summit Therapeutics is still looking...
In children in the US and UK, a sudden increase in the number of cases of severe acute hepatitis of unknown causes (SAHUC) and pediatric acute...
A new study involving hospitalized women in six African countries from the University of Maryland School of Medicine’s (UMSOM) Institute of Human Virology...
An article published in the journal Frontiers in Cellular and Infection Microbiology reports a study by researchers at the State University of Campinas...
Uvalde Gunman Had Disturbing Past; Carried Around Dead Cat, Was Nicknamed "School Shooter" An interim report by a Texas House committee investigating...
Glenview, Illinois – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical...